Drug profile · INN
guanabenz acetate
WYTENSIN
guanabenz acetate (WYTENSIN) is a adrenergic receptor alpha-2 agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — guanabenz acetate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
guanabenz acetate (WYTENSIN) is a adrenergic receptor alpha-2 agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Adrenergic receptor alpha-2 agonist
Primary target: Adrenergic receptor alpha-2
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is guanabenz acetate?
guanabenz acetate (WYTENSIN) is a adrenergic receptor alpha-2 agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for guanabenz acetate?
WYTENSIN is a marketed brand name for guanabenz acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of guanabenz acetate?
guanabenz acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.